Dear Mojtaba, yes there are ongoing several clinical trials aimed at combining dasatinib in AML CBF patients. I also published in Blood 2013 that the combination of dasa with conventional chemotherapy can enhance AML LSC eradication and based on this paper City of Hope is doing a phase 1 trial in AML. Feel free to email to further discussions. Best Cedric
Interesting question, but I've never heard of this Dasatinib in AML before, however, some reports exist about the use of Sorafenib in AML (not sure if it was Sunitinib, I'll look for this later), and perhaps the target of this TKI in AML cells was identified, paving the way for predictive markers. Thank you. Best regards. Salut †